FDA Approvals for imaging Technology to Flourish the Global Breast Imaging Market

The global breast imaging market is anticipated to grow at a considerable CAGR of 6.3% during the forecast period. The market was valued at $3.7 billion in 2019 and is anticipated to reach $5.6 billion in 2026. The global breast imaging industry is comprised of several players providing imaging technologies for breast cancer. These players across the globe are highly inclined towards the adoption of different growth strategies including capacity expansion, mergers & acquisitions, new imaging technology launch, and technology innovation to remain competitive in the marketplace. For instance, in December 2020, Hologic, Inc., a medical technology company focused on women’s health, has announced that it has received approval from the US FDA for Genius AI detection technology. The Genius AI software is designed to assist radiologists to detect potential cancers in the breast tomosynthesis images. This software aids in the identification and early detection of breast cancer when used with the Genius 3D Mammography exam. 

Browse the full report description of "Global Breast Imaging Market Size, Share & Trends Analysis Report by Ionizing Breast Technologies (Analog Mammography, 3D Breast Tomosynthesis, Cone Beam Computed Tomography (CB-CT), Positron Emission Mammography (PEM), and Molecular Breast Imaging), By Non-Ionizing Breast Technologies (Breast MRI, Breast Ultrasound, Optical Imaging, and Breast Thermography), By Screening Method (Symptomatic Imaging and Asymptomatic Imaging), Forecast Period 2021-2027" at https://www.omrglobal.com/industry-reports/breast-imaging-market

In April 2020, Dilon Technologies Inc., a breast cancer treatment and diagnosis company has acquired the assets of Dune Medical. The device named MarginProbe is the Dune medicals technology, and this allows surgeons to remove additional tissues, assisting to reduce avoidable surgeries. Dillon offers only FDA-approved devices which also includes, Navigator Gamma Probes, a device used for radio-guided lymphatic mapping and tumor localization across the globe. Apart from it, in December 2020, Smart Breast Corp., a company involved in breast cancer screening and detection, has announced the acquisition of Molecular Breast Imaging (MBI) assets from Dilon Technologies, Inc. Thus, the various imaging technologies developed by the key players for breast, and FDA approvals for the innovations in the breast imaging technologies are driving the growth of the global breast imaging market during the forecast period. 

Market Coverage

• The market number available for – 2020-2027
• Base year- 2020
• Forecast period- 2021-2027
• Segment Covered- 

o By Ionizing Technologies

o By Non-Ionizing Technologies

o By Screening Methods

• Regions Covered-

o North America

o Europe

o Asia-Pacific

o Rest of the World

• Competitive Landscape-Aurora Healthcare US Corp., FUJIFILM Holdings America Corp., GE Healthcare, Hologic Inc., Siemens Healthcare GmbH, Koninklijke Philips N.V., Bracco Imaging S.P.A, among others

Key Strategies Adopted by Major Players:

• In April 2020, Bracco Imaging, a diagnostic imaging company, has announced a new initiative named BRACCO CARES. It is a non-promotional program to support the community across the globe during the COVID-19 pandemic. BRACCO CARES is an imaging community to assist the diagnosis, treatment, and care of patients.
• In November 2018, CMR Naviscan Corp., a technology solution for high-resolution diagnostic imaging, has signed an agreement with Mayo Clinic. Both the companies will together develop technologies for breast cancer such as licensed Molecular Breast Imaging (MBI) intellectual property, which is used in the CMR Molecular Imaging LumaGEMMolecular Breast Imaging (MBI) System, manufactured and distributed by CMR Naviscan.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Breast Imaging Market Report Segment

By Ionizing Technologies

• Analog Mammography
• 3D Breast Tomosynthesis
• Cone Beam Computed Tomography (CB-CT)
• Positron Emission Mammography (PEM)
• Molecular Breast Imaging

By Non-Ionizing Technologies

• Breast MRI
• Breast Ultrasound
• Optical Imaging
• Breast Thermography

By Screening Methods

• Symptomatic Imaging  
• Asymptomatic Imaging  

Global Breast Imaging Market Report Segment by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe 

Asia-Pacific

• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific 

Rest of the World

• Latin America 
• Middle East & Africa

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/breast-imaging-market